Antimicrobial Surface Modification Platform
Prevention of microbial contamination and healthcare-associated infections (HAIs)
Pre-clinicalActive
Key Facts
Indication
Prevention of microbial contamination and healthcare-associated infections (HAIs)
Phase
Pre-clinical
Status
Active
Company
About DeBogy Molecular
DeBogy Molecular is a private, preclinical-stage biotech company pioneering a permanent surface modification technology to create self-disinfecting materials. Led by a seasoned CEO and a founding team of surgeon-scientists, the company aims to address healthcare-associated infections (HAIs) and broader microbial contamination through a scalable, biocompatible coating platform. While currently pre-revenue and focused on R&D, DeBogy has demonstrated in vivo efficacy and is positioning its technology for medical, life sciences, and industrial applications.
View full company profile